Eva Fortea Verdejo
Stock Analyst at Wells Fargo
(4.89)
# 272
Out of 4,575 analysts
93
Total ratings
77.8%
Success rate
50.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Eva Fortea Verdejo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CELC Celcuity | Reiterated: Buy | $166 | $82.62 | +100.92% | 6 | Jul 14, 2026 | |
| EXEL Exelixis | Maintained: Hold | $40 → $49 | $55.37 | -11.50% | 4 | Jul 13, 2026 | |
| KNSA Kiniksa Pharmaceuticals International, | Rated: Buy | $57 → $74 | $62.84 | +17.76% | 15 | Jul 13, 2026 | |
| ZYME Zymeworks | Rated: Buy | $34 → $37 | $22.86 | +61.85% | 7 | Jun 30, 2026 | |
| GMAB Genmab | Rated: Buy | $40 | $28.87 | +38.55% | 7 | Jun 29, 2026 | |
| RVMD Revolution Medicines | Rated: Buy | $167 | $189.23 | -11.75% | 10 | Jun 1, 2026 | |
| BCAX Bicara Therapeutics | Rated: Hold | $16 | $27.02 | -40.78% | 10 | Jun 1, 2026 | |
| RLAY Relay Therapeutics | Maintained: Buy | $21 | $18.44 | +13.88% | 9 | May 19, 2026 | |
| ZNTL Zentalis Pharmaceuticals | Rated: Hold | $5 | $4.33 | +15.47% | 1 | May 13, 2026 | |
| IDYA IDEAYA Biosciences | Maintained: Buy | $44 → $48 | $35.40 | +35.59% | 5 | Apr 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 | $35.00 | +71.43% | 3 | Apr 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $8 → $27 | $22.88 | +18.01% | 2 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $30 → $23 | $28.42 | -19.07% | 8 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 | $19.44 | +38.89% | 6 | Oct 23, 2025 |
Celcuity
Jul 14, 2026
Reiterated: Buy
Price Target: $166
Current: $82.62
Upside: +100.92%
Exelixis
Jul 13, 2026
Maintained: Hold
Price Target: $40 → $49
Current: $55.37
Upside: -11.50%
Kiniksa Pharmaceuticals International,
Jul 13, 2026
Rated: Buy
Price Target: $57 → $74
Current: $62.84
Upside: +17.76%
Zymeworks
Jun 30, 2026
Rated: Buy
Price Target: $34 → $37
Current: $22.86
Upside: +61.85%
Genmab
Jun 29, 2026
Rated: Buy
Price Target: $40
Current: $28.87
Upside: +38.55%
Revolution Medicines
Jun 1, 2026
Rated: Buy
Price Target: $167
Current: $189.23
Upside: -11.75%
Bicara Therapeutics
Jun 1, 2026
Rated: Hold
Price Target: $16
Current: $27.02
Upside: -40.78%
Relay Therapeutics
May 19, 2026
Maintained: Buy
Price Target: $21
Current: $18.44
Upside: +13.88%
Zentalis Pharmaceuticals
May 13, 2026
Rated: Hold
Price Target: $5
Current: $4.33
Upside: +15.47%
IDEAYA Biosciences
Apr 14, 2026
Maintained: Buy
Price Target: $44 → $48
Current: $35.40
Upside: +35.59%
Apr 14, 2026
Maintained: Buy
Price Target: $60
Current: $35.00
Upside: +71.43%
Mar 24, 2026
Upgraded: Buy
Price Target: $8 → $27
Current: $22.88
Upside: +18.01%
Feb 12, 2026
Downgraded: Hold
Price Target: $30 → $23
Current: $28.42
Upside: -19.07%
Oct 23, 2025
Maintained: Buy
Price Target: $27
Current: $19.44
Upside: +38.89%